These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Statins and coronary artery disease--it's the clinical endpoints that count. Jackson G Br J Clin Pract; 1997; 51(1):2-3. PubMed ID: 9158261 [No Abstract] [Full Text] [Related]
6. [A new study on hypercholesterolemia. Statin is effective against heart disease]. Olsson AG Lakartidningen; 1996 May; 93(22):2131-3. PubMed ID: 8667843 [No Abstract] [Full Text] [Related]
7. A need to redefine the consensus on the use of statins in coronary heart disease prevention. Fruchart JC Eur Heart J; 2000 Oct; 21(19):1572-3. PubMed ID: 10988008 [No Abstract] [Full Text] [Related]
8. [Are there differences in various statins?]. Otto C; Schwandt P Internist (Berl); 1998 Sep; 39(9):987-93. PubMed ID: 9788127 [No Abstract] [Full Text] [Related]
9. Improved survival with statin therapy. Clem JR S D J Med; 1996 Aug; 49(8):273-4. PubMed ID: 8803474 [No Abstract] [Full Text] [Related]
10. Comparison of the efficacy, safety and tolerability of simvastatin and pravastatin. Emmerich J Am J Cardiol; 1994 Apr; 73(9):723-4. PubMed ID: 8166080 [No Abstract] [Full Text] [Related]
11. Recent developments in coronary heart disease prevention: the Scandinavian and west of Scotland studies. Elam MB; Cushman W; Applegate WB; Heimberg M Tenn Med; 1997 May; 90(5):189-92. PubMed ID: 9130876 [No Abstract] [Full Text] [Related]
12. Simvastatin, pravastatin and lovastatin: three options for lowering cholesterol. Holdcroft C Nurse Pract; 1993 May; 18(5):56-7. PubMed ID: 8355901 [No Abstract] [Full Text] [Related]
13. Cholesterol lowering: perspectives on the 4S and West of Scotland studies. Olin JW Cleve Clin J Med; 1996; 63(2):80-3. PubMed ID: 8819689 [No Abstract] [Full Text] [Related]
14. Statins do more than just lower cholesterol. Vaughan CJ; Murphy MB; Buckley BM Lancet; 1996 Oct; 348(9034):1079-82. PubMed ID: 8874463 [No Abstract] [Full Text] [Related]
15. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice. Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658 [TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences. Lennernäs H; Fager G Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173 [TBL] [Abstract][Full Text] [Related]